These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4470109)

  • 1. [Biological exploration of Paget's disease (author's transl)].
    Nagant de Deuxchaisnes C; Rombouts-Lindemans C
    J Belge Rhumatol Med Phys; 1974; 29(5-6):243-92. PubMed ID: 4470109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bone mineral measurement in Paget's disease].
    Nuti R; Vattimo A
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):141-5. PubMed ID: 737061
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological exploration of Paget's disease (author's transl)].
    Nagant de Deuxchaisnes C; Rombouts-Lindemans C
    Acta Orthop Belg; 1974; 40(4):375-424. PubMed ID: 4620051
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG; Birge SJ; Avioli LV
    N Engl J Med; 1970 Sep; 283(11):549-55. PubMed ID: 5450609
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hydroxyproline excretion in the urine in Paget's osteodystrophia deformans. Comparative clinical, morphological and biochemical studies].
    Raab W; Czitober H
    Wien Klin Wochenschr; 1967 Feb; 79(5):91-3. PubMed ID: 5591364
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP; Daumont A; Bouvier M; Lejeune E
    Nouv Presse Med; 1978 Nov; 7(41):3753-6. PubMed ID: 733525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decrease of the coefficient of intestinal calcium absorption with normal blood levels of 1,25-dihydroxyvitamin D and decreasing levels of 24,25-dihydroxyvitamin D in Paget's disease of bone].
    Traba ML; Climent P; Rapado A; de la Piedra C; Díaz Curiel M
    Rev Clin Esp; 1986 Nov; 179(8):401-3. PubMed ID: 3494277
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical markers of bone turnover in Paget's disease of bone.
    Eastell R
    Bone; 1999 May; 24(5 Suppl):49S-50S. PubMed ID: 10321928
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological and isotope explorations in Paget's disease of bone].
    Dell'Anno R; Eisinger J; Recordier AM
    Rhumatologie; 1971 Apr; 23(4):119-39. PubMed ID: 4254981
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Paget's disease with fluoride.
    Riggs BL; Jowsey J
    Semin Drug Treat; 1972; 2(1):65-8. PubMed ID: 4558758
    [No Abstract]   [Full Text] [Related]  

  • 11. Determinants of remission of Paget's disease of bone.
    Patel S; Stone MD; Coupland C; Hosking DJ
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Paget's disease with a diphosphonate (sodium etidronate).
    Smith R; Russell RG
    Semin Drug Treat; 1972; 2(1):77-81. PubMed ID: 4558759
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
    Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of skeletal blood flow in normal man and in patients with Paget's disease of bone.
    Wootton R; Reeve J; Veall N
    Calcif Tissue Res; 1976 Aug; 21 Suppl():380-5. PubMed ID: 782666
    [No Abstract]   [Full Text] [Related]  

  • 17. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of variations in several biological parameters in Paget's disease (phosphatases, hydroxyproline...) before and after treatment with aspirin].
    Galmiche P; Lévy P
    Rev Rhum Mal Osteoartic; 1967 Apr; 34(4):185-92. PubMed ID: 6059924
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A; Baker RK; Wallach S
    Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH; Avery S; Johnston CC
    J Clin Endocrinol Metab; 1970 Sep; 31(3):283-90. PubMed ID: 4916538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.